Highly-Immunogenic Virally-Vectored T-cell Vaccines Cannot Overcome Subversion of the T-cell Response by HCV during Chronic Infection. (2016)

First Author: Swadling L
Attributed to:  Immunity in the face of diversity and the development of novel potent HCV vaccines funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3390/vaccines4030027

PubMed Identifier: 27490575

Publication URI: http://europepmc.org/abstract/MED/27490575

Type: Journal Article/Review

Volume: 4

Parent Publication: Vaccines

Issue: 3

ISSN: 2076-393X